This inventor holds 1 USPTO granted patent. Top assignee: Bial Industrial Farmaceutica, S.a.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Celebrating the Innovations of Juan Andres Asturias
Introduction
Juan Andres Asturias is an innovative inventor based in Getxo, Spain, known for his contributions to the field of biotechnology. With a focus on allergy prevention and treatment, his work in recombinant DNA technology has the potential to make significant advancements in healthcare. Notably, he has been awarded one patent, showcasing his commitment to innovation in the pharmaceutical industry.
Latest Patents
The patent held by Juan Andres Asturias relates to recombinant DNA molecules that encode chimeric polypeptides. These polypeptides are designed to target various allergens, particularly those related to pollen allergies. The invention introduces chimeric polypeptides composed of fragments from allergens Par j 1 and Par j 2, which possess hypoallergenic characteristics. Additionally, the patent outlines methods for producing these recombinant polypeptides in heterologous expression systems and includes efficient purification techniques for the chimeric proteins.
Career Highlights
Juan Andres Asturias is associated with Bial Industrial Farmaceutica, S.A., a prominent pharmaceutical company. His role within the organization underscores his dedication to research and development in the biotech sector, focusing on innovative solutions for allergens and their impact on human health.
Collaborations
Throughout his career, Juan has collaborated with talented individuals such as Alberto Martinez Garate and Roberto Gonzales Rioja. These partnerships enhance his research capabilities and contribute to the collective knowledge in the field of allergy treatment.
Conclusion
Juan Andres Asturias's work exemplifies the spirit of innovation, particularly in the realm of allergy treatment and biotechnology. With his patented technology, he is paving the way for new therapeutic options that could benefit many individuals suffering from allergies. His contributions to the field are essential in moving towards a future with improved healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile